Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Advantage: Novo has the advantage of having the first-mover status in both the diabetes and obesity markets, with strong brand recognition
When the body consumes fewer calories than it needs, it seeks energy from internal stores
Argiolas A, Melis MR, Murgia S, Schioth HB
Ideal for post-procedure recovery products
You have done the counting
| Frequently asked questions | Take home message The Wegovy pill was approved by the UKs medicines regulator, the MHRA, on 11th June 2026, the first weight-loss tablet of its kind in the UK
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
